Concord Biotech Limited — Board Meeting, 29-05-2025: Outcome of Board Meeting

Concord Biotech has announced a board meeting on May 29, 2025, approving audited consolidated financial results for the quarter and year ended March 31, 2025. Revenue jumped to Rs. 1,200 Cr, with profit after tax climbing 20% YoY to Rs. 371.64 Cr. The board proposed a strong dividend of Rs. 10.70 per share. Key leadership changes include Ms. Hina Patel appointed as Company Secretary and Compliance Officer. New auditors have been appointed for FY26, signaling a sharpened focus on governance and compliance.